1. Home
  2. Labeler Index
  3. Mylan Specialty L.p.
  4. 49502-806
  5. NDC Package Code: 49502-806-93 Yupelri

NDC Package 49502-806-93 Yupelri

Revefenacin Solution Respiratory (inhalation) - View Billable Units, 11-Digit Format, RxNorm

Table of Contents

    1. Package Information
    2. NDC HCPCS Crosswalk
    3. Other Packages
    4. Frequently Asked Questions

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
49502-806-93
Package Description:
30 POUCH in 1 CARTON / 1 VIAL, SINGLE-DOSE in 1 POUCH (49502-806-32) / 3 mL in 1 VIAL, SINGLE-DOSE
Product Code:
49502-806
Proprietary Name:
Yupelri
Non-Proprietary Name:
Revefenacin
Substance Name:
Revefenacin
Usage Information:
Revefenacin is a long-term medication used to treat an ongoing lung disease, chronic obstructive pulmonary disease (COPD). It must be used regularly to reduce and prevent symptoms such as shortness of breath, cough, and wheezing. This medication belongs to a class of drugs known as anticholinergics. It works by relaxing the muscles around the airways so that they open up and you can breathe more easily. Revefenacin does not work right away and should not be used to relieve sudden breathing problems. If wheezing or sudden shortness of breath occurs, use your quick-relief inhaler as prescribed.
11-Digit NDC Billing Format:
49502080693
Billing Unit:
ML - Billing unit of "milliliter" is used when a product is measured by its liquid volume.
NDC to RxNorm Crosswalk:
  • RxCUI: 2102779 - revefenacin 175 MCG in 3 ML Inhalation Solution
  • RxCUI: 2102779 - revefenacin 0.0583 MG/ML Inhalation Solution
  • RxCUI: 2102779 - revefenacin 175 MCG per 3 ML Inhalation Solution
  • RxCUI: 2102784 - YUPELRI 175 MCG in 3 ML Inhalation Solution
  • RxCUI: 2102784 - revefenacin 0.0583 MG/ML Inhalation Solution [Yupelri]
    • Product Type:
    Human Prescription Drug
    Labeler Name:
    Mylan Specialty L.p.
    Dosage Form:
    Solution - A clear, homogeneous liquid1 dosage form that contains one or more chemical substances dissolved in a solvent or mixture of mutually miscible solvents.
    Administration Route(s):
  • Respiratory (inhalation) - Administration within the respiratory tract by inhaling orally or nasally for local or systemic effect.
    • Active Ingredient(s):
  • REVEFENACIN 175 ug/3mL
    • Pharmacologic Class(es):
  • Anticholinergic - [EPC] (Established Pharmacologic Class)
  • Cholinergic Antagonists - [MoA] (Mechanism of Action)
    • Sample Package:
    No
    FDA Application Number:
    NDA210598
    Marketing Category:
    NDA - A product marketed under an approved New Drug Application.
    Start Marketing Date:
    12-03-2018
    Listing Expiration Date:
    12-31-2024
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    NDC HCPCS Crosswalk

    This crosswalk is intended to help the public understand which drug products (identified by NDCs) are assigned to which HCPCS billing codes.

    NDC 49502-806-93 HCPCS crosswalk information with package details and bill units information.

    NDC Billing CodeHCPCS CodeHCPCS Code Desc.DosagePackage SizePackage QuantityBillable UnitsBillable Units / Pkg
    49502080693J7677Revefenacin inh non-com 1mcg1 MCG3301755250

    * Please review the disclaimer below.

    Other Product Packages

    The following packages are also available for this product:

    NDC Package CodePackage Description
    49502-806-877 POUCH in 1 CARTON / 1 VIAL, SINGLE-DOSE in 1 POUCH (49502-806-33) / 3 mL in 1 VIAL, SINGLE-DOSE

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 49502-806-93?

    The NDC Packaged Code 49502-806-93 is assigned to a package of 30 pouch in 1 carton / 1 vial, single-dose in 1 pouch (49502-806-32) / 3 ml in 1 vial, single-dose of Yupelri, a human prescription drug labeled by Mylan Specialty L.p.. The product's dosage form is solution and is administered via respiratory (inhalation) form.

    Is NDC 49502-806 included in the NDC Directory?

    Yes, Yupelri with product code 49502-806 is active and included in the NDC Directory. The product was first marketed by Mylan Specialty L.p. on December 03, 2018 and its listing in the NDC Directory is set to expire on December 31, 2024 if the product is not updated or renewed by the manufacturer.

    What is the NDC billing unit for package 49502-806-93?

    The contents of this package are billed per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.

    What is the 11-digit format for NDC 49502-806-93?

    The 11-digit format is 49502080693. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    5-3-249502-806-935-4-249502-0806-93